We are live on ! Find out more
NKTR icon

Nektar Therapeutics
NKTR

139 hedge funds and large institutions have $1.18B invested in Nektar Therapeutics in 2013 Q2 according to their latest regulatory filings, with 139 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

687% more call options, than puts

Call options by funds: $12.7M | Put options by funds: $1.62M

Holders
139
Holders Change
+139
Holders Change %
–
% of All Funds
4.54%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
139
Increased
–
Reduced
–
Closed
–
Calls
$12.7M
Puts
$1.62M
Net Calls
+$11.1M
Net Calls Change
+$11.1M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS AM
26
UBS AM
Illinois
$8.93M +$7.9M +51,521 New
Norges Bank
27
Norges Bank
Norway
$8.89M +$7.87M +51,311 New
TCIM
28
TIAA CREF Investment Management
New York
$8.56M +$7.58M +49,411 New
VOYA Investment Management
29
VOYA Investment Management
Georgia
$8.48M +$7.51M +48,937 New
TL
30
Tirschwell & Loewy
New York
$6.34M +$5.61M +36,604 New
Allianz Asset Management
31
Allianz Asset Management
Germany
$6.32M +$5.59M +36,460 New
Geode Capital Management
32
Geode Capital Management
Massachusetts
$5.8M +$5.14M +33,501 New
D.E. Shaw & Co
33
D.E. Shaw & Co
New York
$5.55M +$4.92M +32,049 New
Deutsche Bank
34
Deutsche Bank
Germany
$5.53M +$4.9M +31,921 New
Morgan Stanley
35
Morgan Stanley
New York
$5.47M +$4.84M +31,548 New
CS
36
Credit Suisse
Switzerland
$5.07M +$4.49M +29,253 New
William Blair & Company
37
William Blair & Company
Illinois
$3.99M +$3.53M +23,013 New
AllianceBernstein
38
AllianceBernstein
Tennessee
$3.88M +$3.43M +22,368 New
BIM
39
BlackRock Investment Management
Delaware
$3.87M +$3.43M +22,346 New
Millennium Management
40
Millennium Management
New York
$3.81M +$3.37M +21,970 New
Charles Schwab
41
Charles Schwab
California
$3.55M +$3.04M +19,800 New
Goldman Sachs
42
Goldman Sachs
New York
$3.32M +$2.94M +19,178 New
NIP
43
Nicholas Investment Partners
California
$3.21M +$2.84M +18,501 New
Axa
44
Axa
France
$2.97M +$2.63M +17,118 New
GC
45
Guggenheim Capital
Illinois
$2.96M +$2.62M +17,109 New
PP
46
PDT Partners
New York
$2.85M +$2.53M +16,477 New
Barclays
47
Barclays
United Kingdom
$2.75M +$2.44M +15,893 New
Fidelity Investments
48
Fidelity Investments
Massachusetts
$2.62M +$2.32M +15,140 New
USAA
49
United Services Automobile Association
Texas
$2.61M +$2.31M +15,060 New
TA
50
Teachers Advisors
New York
$2.42M +$2.14M +13,941 New
1
2
3 4 5

NKTR Hedge Fund Activity: Q2 2013 in Review

139 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Nektar Therapeutics (NKTR) for Q2 2013, worth a combined $1.18B.

Buyers outnumbered sellers: 139 funds opened new NKTR positions and 0 closed out — a net gain of 139 holders — while 0 added to existing stakes and 0 trimmed.

  • 139 institutional investors held Nektar Therapeutics (NKTR) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.18B of Nektar Therapeutics stock for Q2 2013.
  • 139 funds opened new Nektar Therapeutics positions in Q2 2013 and 0 closed out, a net change of +139 holders.

Based on aggregated 13F filings for Q2 2013.